2026 Discovery Grant Program

Brain Canada and the ALS Society of Canada are thrilled to announce the launch of the 2026 Discovery Grant Program. The purpose of the 2026 Discovery Grant Program is to invest in high-impact projects focused on identifying causes of, or treatments for, ALS and/or related neurological diseases, including primary lateral sclerosis, progressive muscular atrophy, and ALS/FTLD (frontotemporal lobar dementia) or advancing research aimed at maximizing function, minimizing disability, and optimizing quality of life through symptom management and support for individuals or families living with ALS.